Deals channel feed – Endpoints News

Deals channel feed

Roche initially didn't want to buy Poseida — and partner Astellas didn't submit an offer, new filings show

5 months ago

'It's the biology, stupid': Relation and GSK team up on fibrosis, osteoarthritis

5 months ago

European Commission greenlights $16.5B Novo-Catalent acquisition

5 months ago

Eliav Barr defends Merck's LaNova deal, but cautions VEGF bispecifics have yet to deliver mature data

5 months ago

Genmab licenses second monoclonal antibody from Scancell

5 months ago

GSK's third new pact of the week focuses on Alzheimer's with startup Muna Therapeutics

5 months ago

GSK extends Shingrix pact in China but for less money, adds RSV vaccine deal

5 months ago

Novavax sells Czech facility to Novo Nordisk for $200M to cut costs

5 months ago

GSK partners with Rgenta on RNA-targeted small molecules for oncology, other areas

5 months ago

Dewpoint partners its ALS program, eyes JPM to raise a Series D

5 months ago

GSK makes another ADC deal, this time with BioNTech's partner DualityBio

5 months ago

Coherus makes final, $483M pivot away from biosimilars

5 months ago

Ipsen secures rights to preclinical T cell engager in $610M pact with French biotech

5 months ago

Relay licenses cancer drug to Korean biotech for $75M

5 months ago

Takeda to pay $200M for rights to anemia drug from Keros

5 months ago

Gilead makes another ADC move, inking up to $415M pact with Tubulis

5 months ago

Roche teams up with Chicago autoimmune biotech COUR Pharmaceuticals

5 months ago

Olema, Novartis ink another agreement, this time for a late-stage breast cancer trial

5 months ago

Novartis pays $1B upfront for PTC's Phase 2 Huntington's drug

5 months ago

Acadia snaps up an essential tremor drug after field's summer setbacks

5 months ago

Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runway

5 months ago

Sarepta licenses Arrowhead's RNA-based rare disease pipeline, promising big biobucks

5 months ago

Updated: Roche buys out CAR-T partner Poseida for $1B upfront

5 months ago

Cradle Bio raises $73M Series B to sell pharma its protein-making AI software

5 months ago

First page Previous page 5 6 789 10 11 Next page Last page